Immediate Impact

1 by Nobel laureates 4 from Science/Nature 71 standout
Sub-graph 1 of 23

Citing Papers

The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
2 intermediate papers

Works of Christopher Sweeney being referenced

A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal Cancer
2005
A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy
2004

Author Peers

Author Last Decade Papers Cites
Christopher Sweeney 93 173 46 93 14 282
Katherine Tkaczuk 41 157 13 99 17 313
Yi Zhang 66 126 36 46 16 330
Li Zhang 52 125 43 95 22 298
Ruben A.G. van Eerden 74 99 45 72 24 299
Theresa Westphal 53 167 18 52 13 241
Marita Prohn 46 120 53 45 16 298
Kelsey Klute 61 159 47 124 25 329
W. Messersmith 87 203 22 95 9 298
V. Barley 79 58 51 31 14 242
Sara Nunnery 80 110 20 148 14 326

All Works

Loading papers...

Rankless by CCL
2026